-
Pediatric advanced airway management is a critical intervention performed for ill or injured children in the emergency department (ED). Approximately 270,000 children require endotracheal intubation in the emergency department each year, comprising 0.2% of all ED visits.
-
In a series of recent decisions, the Georgias appellate and supreme courts diluted application of the clear and convincing gross negligence standard installed by Georgias tort reform statute; and they have also advanced exceptions to the law that allow plaintiff attorneys to circumvent the legislatures intended tougher standards required to prove medical malpractice.
-
A patient with a chief complaint of back pain also reported leg weakness to the emergency physician (EP) evaluating him, but the EP assumed the weakness was related to the back pain.
-
A recent malpractice case involved an elderly man who was diagnosed with a gastrointestinal (GI) bleed by an emergency physician (EP), who determined that the patient should be admitted.
-
A patients history frequently becomes an issue in malpractice claims against emergency physicians (EPs), says Phillip B. Toutant, Esq., an attorney in the Southfield, MI, office of The Health Law Partners
-
Oculopharyngeal muscular dystrophy is a rare, autosomal dominant neuromuscular disorder that has recently been genetically defined and may be treatable with myoblast transplantation.
-
Malpractice claims involving care provided at the University of Michigan Health System in Ann Arbors three emergency departments (EDs) decreased by about half in the past decade, after a disclosure, apology, and compensation program was implemented, estimates Richard C. Boothman, JD, executive director for clinical safety and chief risk officer
-
The Montreal Cognitive Assessment and Mini-Mental Status Exam demonstrated baseline deficits in early Parkinsons disease.
-
Blood Pressure Variability May Predict Poor Outcome After Intracerebral Hemorrhage
-
A Phase 2 trial of atacicept, a humanized recombinant protein that suppresses B cell function, demonstrated a negative impact on clinical disease activity in relapsing-remitting multiple sclerosis.